The monoclonal antibody therapeutics market to reach $497.5 billion
The landscape of modern medicine is witnessing a paradigm shift with the rapid advancement of monoclonal antibody (mABs) therapeutics. These innovative treatments hold immense promise in addressing a wide spectrum of diseases, ranging from cancer to autoimmune disorders. In this article, we explore the dynamics …